Overview
News
Technologies
Salaries
Products
People
Growth
Offices
Financials
Funding and backers
Total raised
$120M
1 round on record
Latest round
$120M
Series B · Oct 2024 · 23 mo ago
Team
120
US Form 5500 (plan participants) · Sep 2025
Hiring now
3
+2 posted in 30 days
Backers
1
Madrona
The money's age
Due for its next round
23 months since the last round · and hiring
Momentum
37/100
hiring for its size, a new city
Last sign of life
this month
a posting or a news item
The story so fareach stage dated by its source: the company's releases, the press, registers, filings
Dec 18, 2024
Partnership Gilead and Terray Therapeutics collaborate on drug discovery · bioworld.com
Oct 22, 2024
Raised a round Series B $120M · Pulse 2.0
Tractionpublic signals, read monthly
Web presence
top 7%
of 133.2M domains by links, Common Crawl
Funding rounds
| Round | Date | Amount | Investors | Source |
|---|---|---|---|---|
| Series B | Oct 2024 | $120M | — | Pulse 2.0 |
Backed byfrom the funds' portfolios and accelerator catalogs
Madrona Investors in similar startupsfunds that back the companies most like this one
Similar startupsby what they do, their industry and backers
Light Horse is a small molecule drug discovery company that is leading the way in a.
SYNthesis Med Chem is a global provider of small molecule drug discovery services and offers a unique support to drug discovery projects.
Variational AI is a Canadian technology company founded in 2019 and based in Vancouver. It builds generative models that design small…
Genesis Molecular AI is a drug discovery company headquartered in Burlingame, California, and founded in 2019. The company combines deep…
AI-powered gene expression models predict human tissue responses to drugs. De-risk clinical trials, optimize patient selection, and…
Iambic Therapeutics combines machine learning with automated chemistry to discover small molecule drugs. Its NeuralPLexer models predict…
Visa sponsorship
- United States · H-1B filings in 12 months: 5 · green card filings: 1
News
Report
Feb 12, 2026 EndPoints Terray says its AI model beats a popular open-source model at predicting how molecules bind with proteins
Read more
Report
TerraBind: Fast and Accurate Binding Affinity Prediction through Coarse Structural Representations
Abstract page for arXiv paper 2602.07735: TerraBind: Fast and Accurate Binding Affinity Prediction through Coarse Structural Representations
Read more
Report
Introducing EMMI: Where Experimentation Meets Machine Intelligence - Terray Therapeutics
Terray's AI-Native Platform is Turning the Impossible into Predictable to Deliver for Patients
Read more
Report
Daily News
The Los Angeles Daily News is the local news source for Los Angeles and the San Fernando Valley region, providing breaking news, sports, business, entertainment, things to do, opinion, photos, videos and more from L.A.
Read more
Report
Gilead and Terray Therapeutics collaborate on drug discovery
Gilead Sciences Inc. and Terray Therapeutics Inc. have entered into a strategic collaboration to discover and develop novel small-molecule therapies across multiple targets.
Read more
Report
Gilead and Terray Therapeutics Announce Multi-Target Research Collaboration to Discover and Develop Novel Small Molecule Therapies
FOSTER CITY, Calif.& LOS ANGELES---- Gilead Sciences, Inc. and Terray Therapeutics, Inc. announced today that the companies have entered into a strategic collaboration to discover and develop novel, small molecule therapies across multiple targets. "Next-
Read more
Report
Odyssey Therapeutics and Terray Therapeutics Enter Strategic Collaboration to Jointly Discover and Develop First-in-Class Transcription Factor Therapies
Read more
Report
Terray Therapeutics: $120 Million (Series B) Secured To Improve Human Health
Terray Therapeutics, a biotechnology company focused on improving human health by transforming the speed, cost, and success rate of small molecule drug development using computation integrated with novel data at scale, announced Series B funding of $120 m
Read more
Report
Show more news
Tech stack
Technologies named in job postings at Terray Therapeutics over the last 12 months, by layer, with the share of postings for each.
Technologies in use
7
Postings analysed
7
Stack modernity
79/100
Languages
C#
Java
Python
Cloud & platforms
.NET
Developer tools
SolidWorks
Practices & domains
Machine Learning
AI Agents
Sign in to see how your skills match this stack
Sign In
Salary insights
Compensation ranges based on this company's open jobs
Median
$175k
Typical range
$78k – $263k
Open positions
3
3
Jobs
Junior
33.3%
Staff
33.3%
Principal
33.3%
| Level | Jobs | Median | Typical range |
|---|---|---|---|
| Junior | 1 | $78k | $78k |
| Staff | 1 | $175k | $175k |
| Principal | 1 | $263k | $263k |
Highest paying role
Principal Scientist, Protein Biochemistry and Structural Biology
$263k
Normalized to USD per year
Growth
Hiring Momentum
83/100
Scaling fast
Open positions
3
2 opened / 2 closed in 30 days
Median time-to-fill
69 days
faster than 20% of the market
ATS activity
Every ~3 hours
Today
Hiring Dynamics
+100%
Hiring Focus
The percentage next to each role is its share of the company's job openings over the last 90 days; the arrow shows the shift versus the previous period.
Product
25% ▼
Management
25% ▼
Science & Research
25% ▲
Field & Service
25% ▲
Activity Timeline
New location: Monrovia
Sep 2026
Added Machine Learning to stack
Sep 2026
Added Agile to stack
Sep 2026
Added SolidWorks to stack
Aug 2026
Added Python to stack
Aug 2026
Added Java to stack
Aug 2026
Added C# to stack
Aug 2026
Added .NET to stack
Aug 2026
Offices
Where the company hires and what each office is for
Cities
1
Hiring now
1
Countries
1
Busiest office
Monrovia
Monrovia
United States
Regional office
3 open roles 2 posted in 90 days 67% engineering 50-200 est. staff $172k Avg Salary
hires for Science & Research, Field & Service
Financials
Total raised
$120M
Latest round
Series B
Funding rounds
1
Funding rounds
| Round | Announced | Amount | |
|---|---|---|---|
| Series B | 2024 | $120M | Details |